Analytical validation of a multi-cancer early detection test with cancer signal origin using a cell-free DNA-based targeted methylation assay

被引：11

作者：

Alexander, Gregory E. ^{[1
]}

Lin, Wendy ^{[1
,2
]}

Ortega, Fabian E. ^{[1
,3
]}

Ramaiah, Madhuvanthi ^{[1
,4
]}

Jung, Byoungsok ^{[1
]}

Ji, Lijuan ^{[1
]}

Revenkova, Ekaterina ^{[1
]}

Shah, Payal ^{[1
,5
]}

Croisetiere, Christian ^{[1
]}

Berman, Jennifer R. ^{[1
]}

Eubank, Lane ^{[1
]}

Naik, Gunjan ^{[1
,6
]}

Brooks, Jacqueline ^{[1
]}

Mich, Andrea ^{[1
]}

Shojaee, Seyedmehdi ^{[1
]}

Ronaghi, Neda ^{[1
]}

Chawla, Hemanshi ^{[1
]}

Hou, Xinyi ^{[1
]}

Liu, Qinwen ^{[1
]}

Yakym, Christopher-James A. V. ^{[1
]}

Moradi, Patriss Wais ^{[1
]}

Halks-Miller, Meredith ^{[1
,7
]}

Aravanis, Alexander M. ^{[1
,8
]}

Parpart-Li, Sonya ^{[1
]}

Hunkapiller, Nathan ^{[1
]}

机构：

[1] GRAIL LLC, Menlo Pk, CA 94025 USA

[2] Genentech Inc, South San Francisco, CA USA

[3] Olema Oncol, San Francisco, CA USA

[4] PrognomiQ Inc, San Mateo, CA USA

[5] Roche Diagnost, Santa Clara, CA USA

[6] Cepheid, Sunnyvale, CA USA

[7] Delfi Diagnost, Palo Alto, CA USA

[8] Illumina Inc, San Diego, CA USA

来源：

PLOS ONE | 2023年 / 18卷 / 04期

关键词：

CIRCULATING TUMOR DNA; LIQUID BIOPSY; PERSPECTIVE;

D O I：

10.1371/journal.pone.0283001

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The analytical validation is reported for a targeted methylation-based cell-free DNA multi-cancer early detection test designed to detect cancer and predict the cancer signal origin (tissue of origin). A machine-learning classifier was used to analyze the methylation patterns of >10(5) genomic targets covering >1 million methylation sites. Analytical sensitivity (limit of detection [95% probability]) was characterized with respect to tumor content by expected variant allele frequency and was determined to be 0.07%-0.17% across five tumor cases and 0.51% for the lymphoid neoplasm case. Test specificity was 99.3% (95% confidence interval, 98.6-99.7%). In the reproducibility and repeatability study, results were consistent in 31/34 (91.2%) pairs with cancer and 17/17 (100%) pairs without cancer; between runs, results were concordant for 129/133 (97.0%) cancer and 37/37 (100%) non-cancer sample pairs. Across 3- to 100-ng input levels of cell-free DNA, cancer was detected in 157/182 (86.3%) cancer samples but not in any of the 62 non-cancer samples. In input titration tests, cancer signal origin was correctly predicted in all tumor samples detected as cancer. No cross-contamination events were observed. No potential interferent (hemoglobin, bilirubin, triglycerides, genomic DNA) affected performance. The results of this analytical validation study support continued clinical development of a targeted methylation cell-free DNA multi-cancer early detection test.

引用

页数：23

共 28 条

[11]

Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P674, DOI [10.1001/jama.2018.10897, 10.1097/01.ogx.0000549540.69362.81]

[12] Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set [J].

Klein, E. A. ;

Richards, D. ;

Cohn, A. ;

Tummala, M. ;

Lapham, R. ;

Cosgrove, D. ;

Chung, G. ;

Clement, J. ;

Gao, J. ;

Hunkapiller, N. ;

Jamshidi, A. ;

Kurtzman, K. N. ;

Seiden, M., V ;

Swanton, C. ;

Liu, M. C. .

ANNALS OF ONCOLOGY, 2021, 32 (09) :1167-1177

[13] Development of a comprehensive cell-free DNA (cfDNA) assay for early detection of multiple tumor types: The Circulating Cell-free Genome Atlas (CCGA) study. [J].

Klein, Eric A. ;

Hubbell, Earl ;

Maddala, Tara ;

Aravanis, Alex ;

Beausang, John F. ;

Filippova, Darya ;

Gross, Samuel ;

Jamshidi, Arash ;

Kurtzman, Kathryn ;

Shen, Ling ;

Valouev, Anton ;

Venn, Oliver ;

Zhang, Nan ;

Smith, David A. ;

Yeatman, Timothy Joseph ;

Tibshirani, Robert ;

Williams, Richard Thomas ;

Hartman, Anne-Renee ;

Seiden, Michael ;

Liu, Minetta C. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[14] Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA [J].

Liu, M. C. ;

Oxnard, G. R. ;

Klein, E. A. ;

Swanton, C. ;

Seiden, M., V .

ANNALS OF ONCOLOGY, 2020, 31 (06) :745-759

[15]

Liu M.C., 2018, Ann. Oncol, V29, pviii14, DOI [DOI 10.1093/ANNONC/MDY269.048, 10.1093/annonc/mdy269.048]

[16]

Liu MC, 2021, EUR SOC MED ONC C 20

[17] Circulating Tumor DNA Analysis in Patients With Cancer American Society of Clinical Oncology and College of American Pathologists Joint Review [J].

Merker, Jason D. ;

Oxnard, Geoffrey R. ;

Compton, Carolyn ;

Diehn, Maximilian ;

Hurley, Patricia ;

Lazar, Alexander J. ;

Lindeman, Neal ;

Lockwood, Christina M. ;

Rai, Alex J. ;

Schilsky, Richard L. ;

Tsimberidou, Apostolia M. ;

Vasalos, Patricia ;

Billman, Brooke L. ;

Oliver, Thomas K. ;

Bruinooge, Suanna S. ;

Hayes, Daniel F. ;

Turner, Nicholas C. .

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (10) :1242-1253

[18] Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement [J].

Moyer, Virginia A. .

ANNALS OF INTERNAL MEDICINE, 2014, 160 (05) :330-+

[19]

Ou Sai-Hong Ignatius, 2018, Am Soc Clin Oncol Educ Book, V38, P978, DOI 10.1200/EDBK_199765

[20]

Oxnard GR, 2019, ANN ONCOL, V30, P912

← 1 2 3 →